Martin Shkreli Barred From Drug Industry and Must Repay $64.6 Million

Martin Shkreli Barred From Drug Industry and Must Repay $64.6 Million

Martin Shkreli is barred from the drug industry and ordered to repay $64.6 million. Martin Shkreli, the former pharmaceutical executive best known for unapologetically hiking the price of a lifesaving medication, must pay $64.6 million and will be barred for life from the drug industry for violating antitrust law, a federal court ordered on Friday. Mr. Shkreli is serving a seven-year prison sentence for defrauding investors related to his work running two hedge funds and a different pharmaceutical company. That conviction is unrelated to the drug pricing saga that elevated him to notoriety. He is expected to be released this year. In 2015, Mr. Shkreli — then a pharmaceutical entrepreneur in his early 30s not well known outside his industry — acquired a decades-old drug known as Daraprim, which is …
More on: www.nytimes.com